𝔖 Bobbio Scriptorium
✦   LIBER   ✦

ChemInform Abstract: The Thiazolidinediones — A Novel Approach for the Treatment of Type-2 Diabetes

✍ Scribed by H. BETHGE; H. U. HAERING

Publisher
John Wiley and Sons
Year
2010
Weight
24 KB
Volume
29
Category
Article
ISSN
0931-7597

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel therapeutic strategies for the tre
Novel therapeutic strategies for the treatment of Type 2 diabetes
✍ Perfetti, Riccardo ;Barnett, Philip S ;Mathur, Ruchi ;Egan, Josephine M 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB 👁 1 views

Diabetes mellitus is the most common endocrine disease, accounting for over 200 million people affected worldwide. It is characterized by a lack of insulin secretion and/or increased cellular resistance to insulin, resulting in hyperglycemia and other metabolic disturbances. People with diabetes suf

ChemInform Abstract: The Asymmetric Synt
ChemInform Abstract: The Asymmetric Synthesis of Sitagliptin, a Selective Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes.
✍ Feng Liu; Wansheng Yu; Wenhua Ou; Xiaoke Wang; Libo Ruan; Yiming Li; Xijiang Pen 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 23 KB

## Abstract Key step in the improved synthetic pathway to sitagliptin (VII), a new DPP‐IV inhibitor for the treatment of type 2 diabetes mellitus, is an asymmetric Michael addition to give intermediate (IV).